Clinical Trials Directory

Trials / Sponsors / CytomX Therapeutics

CytomX Therapeutics

Industry · 9 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingFirst In Human Study of CX-801 in Advanced Solid Tumors
Solid Tumor, Adult
Phase 12024-08-28
RecruitingFirst In Human Study of CX-2051 in Advanced Solid Tumors
Solid Tumor, Adult
Phase 12024-04-02
TerminatedA Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tu
Solid Tumors
Phase 12022-05-16
CompletedStudy to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in A
Neoplasms, Breast Neoplasms, Breast Neoplasms, Triple-Negative
Phase 22020-12-29
WithdrawnPROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Sol
Solid Tumor, Adult
Phase 12020-01-01
TerminatedPROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy i
Solid Tumor, Unresectable or Metastatic Melanoma
Phase 22019-11-20
CompletedPROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With S
Solid Tumor, Adult, Head and Neck Cancer, Non Small Cell Lung Cancer
Phase 1 / Phase 22018-06-15
TerminatedPROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With S
Solid Tumor, Adult, Breast Cancer, Non Small Cell Lung Cancer
Phase 1 / Phase 22017-06-01
TerminatedPROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Sol
Solid Tumor, Lymphoma
Phase 1 / Phase 22017-01-19